MX2024011693A - Inhibidores de tirosina-proteina cinasa 2 (tyk2) y usos de los mismos - Google Patents

Inhibidores de tirosina-proteina cinasa 2 (tyk2) y usos de los mismos

Info

Publication number
MX2024011693A
MX2024011693A MX2024011693A MX2024011693A MX2024011693A MX 2024011693 A MX2024011693 A MX 2024011693A MX 2024011693 A MX2024011693 A MX 2024011693A MX 2024011693 A MX2024011693 A MX 2024011693A MX 2024011693 A MX2024011693 A MX 2024011693A
Authority
MX
Mexico
Prior art keywords
tyk2
tyrosine
inhibitors
protein kinase
inhibition
Prior art date
Application number
MX2024011693A
Other languages
English (en)
Spanish (es)
Inventor
Alan John Collis
Vinayak Hosagrahara
Bhaskar Srivastava
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of MX2024011693A publication Critical patent/MX2024011693A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2024011693A 2022-03-25 2024-09-24 Inhibidores de tirosina-proteina cinasa 2 (tyk2) y usos de los mismos MX2024011693A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263269943P 2022-03-25 2022-03-25
US202263371033P 2022-08-10 2022-08-10
US202363490664P 2023-03-16 2023-03-16
PCT/US2023/064902 WO2023183901A1 (en) 2022-03-25 2023-03-24 Tyk2 inhibitors and uses thereof

Publications (1)

Publication Number Publication Date
MX2024011693A true MX2024011693A (es) 2024-11-08

Family

ID=88102041

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024011693A MX2024011693A (es) 2022-03-25 2024-09-24 Inhibidores de tirosina-proteina cinasa 2 (tyk2) y usos de los mismos

Country Status (10)

Country Link
US (1) US20250213572A1 (enExample)
EP (1) EP4499104A4 (enExample)
JP (1) JP2025510813A (enExample)
KR (1) KR20240165963A (enExample)
AU (1) AU2023237900A1 (enExample)
CA (1) CA3246157A1 (enExample)
CL (1) CL2024002824A1 (enExample)
MX (1) MX2024011693A (enExample)
TW (1) TW202345799A (enExample)
WO (1) WO2023183901A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024263861A2 (en) * 2023-06-23 2024-12-26 Dana-Farber Cancer Institute, Inc. Methods of treating chronic lymphocytic leukemia
EP4780462A1 (en) * 2023-09-21 2026-07-29 Takeda Pharmaceutical Company Limited Tyk2 inhibitors for use in the treatment of inflammatory bowel disease
CN122341608A (zh) * 2023-11-24 2026-07-03 苏州科睿思制药有限公司 Zasocitinib的晶型及其制备方法和用途
WO2026032374A1 (zh) * 2024-08-07 2026-02-12 正大天晴药业集团股份有限公司 含联环的化合物用于治疗银屑病的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL317854A (en) * 2017-07-28 2025-02-01 Takeda Pharmaceuticals Co TYK2 inhibitors and their uses
JP7619951B2 (ja) * 2018-10-15 2025-01-22 武田薬品工業株式会社 Ｔｙｋ２阻害剤およびその使用
US11357775B2 (en) * 2019-04-30 2022-06-14 Celgene Corporation Combination therapies comprising apremilast and Tyk2 inhibitors

Also Published As

Publication number Publication date
US20250213572A1 (en) 2025-07-03
CA3246157A1 (en) 2023-09-28
EP4499104A1 (en) 2025-02-05
AU2023237900A1 (en) 2024-10-10
JP2025510813A (ja) 2025-04-15
EP4499104A4 (en) 2025-09-03
KR20240165963A (ko) 2024-11-25
TW202345799A (zh) 2023-12-01
CL2024002824A1 (es) 2025-02-14
WO2023183901A1 (en) 2023-09-28

Similar Documents

Publication Publication Date Title
CL2022000751A1 (es) Inhibidores de la fosfatasa shp2 y métodos para su uso (divisional de la solicitud no. 202002419)
SA522432225B1 (ar) Cdk2 أمينات ثنائية الحلقة كمثبطات
JOP20210179A1 (ar) مثبطات إيميدازو[1، 2-b] بيريدازين IL-17A
CL2020002146A1 (es) Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer.
CO2021016594A2 (es) Pirroles tricíclicos condensados como moduladores de alfa-1 antitripsina
CL2024002824A1 (es) Inhibidores de tyk2 y usos de los mismos
AR002267A1 (es) Compuestos de imidazol utiles para el tratamiento de patologias mediadas por citoquinas; composicion farmaceutica que los contiene; proceso para preparar dichos compuestos; uso del mismo para preparar dichas composiciones; compuestos intermediarios y procesos para su preparacion.
UY40234A (es) Compuestos heteroarilo para el tratamiento del dolor
UY28059A1 (es) Nuevos derivados de dihidropirimido (4,5-d) pirimidona sustituida por amino. fabricacion y uso de los mismos como agentes farmaceuticos.
MX2023002324A (es) Tratamiento de trastornos de perdida de cabello con inhibidores de cinasas asociadas a janus (jak) deuterados.
MX2022009043A (es) Compuestos de sulfonimidamida como moduladores de nlrp3.
UY40235A (es) Compuestos de heteroarilo para el tratamiento del dolor
NO20054726L (no) 2, 4-di(fenylamino)pyrimidiner anvendelige ved behandling av neoplastiske sykdommer, inflammasjons- og immunsystemforstyrrelser
NO982185L (no) Nye makrosykliske forbindelser som metalloproteinaseinhibitorer
ATE542818T1 (de) Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung
CL2023002223A1 (es) Inhibidores de cdk2 y métodos de uso de los mismos
PH12022550029A1 (en) Deuterated mk2 pathway inhibitors and methods of using the same
DE602004003806D1 (de) 1-(2H-PYRAZOL-3-YL)-3-ä4-Ä1-(BENZOYL)-PIPERIDIN-4-YLMETHYLÜ-PHENYLü-HARNSTOFFDERIVATE UND VERWANDTE VERBINDUNGEN ALS INHIBITOREN DER P38 KINASE UND/ODER DES TNF ZUR BEHANDLUNG VON ENTZÜNDUNGEN
MX2022008627A (es) Pirazolo-pirimidinas sustituidas y usos de las mismas.
MX389581B (es) Compuestos que contienen nitrogeno sustituido.
NO20000784L (no) Nye aggrecanaseinhibitorer og matriksmetalloproteinaser for behandling av artritt
MX2024007042A (es) Inhibidores de raf quinasa y metodos de uso de los mismos.
MX2021013602A (es) Inhibidores de jak.
JOP20250215A1 (ar) ثيازولو[4،5-d]-بيريميدين-7-ونات كمثبطات NOX4
BR112021026531A2 (pt) Composto, composição farmacêutica, e, método para prevenir ou tratar uma doença mediada pela tirosina cinase 2